M-FasL

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameM-FasL
Drug Alias Namere-engineered Fas ligand (Memgen)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionSoluble Fas ligand modulators
TargetsSoluble Fas ligand
Therapy Area/IndicationsAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMemgen Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMemgen Llc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A